Reply to Letter to the Editor Regarding "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial"

J Bone Miner Res. 2022 Jan;37(1):169-170. doi: 10.1002/jbmr.4456. Epub 2021 Nov 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Diseases, Metabolic*
  • Diphosphonates / therapeutic use
  • Humans
  • Spinal Cord Injuries* / complications
  • Spinal Cord Injuries* / drug therapy
  • Time-to-Treatment
  • Zoledronic Acid / therapeutic use

Substances

  • Diphosphonates
  • Zoledronic Acid